These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 16843837)
1. Pyrazolyl conjugates of bombesin: a new tridentate ligand framework for the stabilization of fac-[M(CO)3]+ moiety. Alves S; Correia JD; Santos I; Veerendra B; Sieckman GL; Hoffman TJ; Rold TL; Figueroa SD; Retzloff L; McCrate J; Prasanphanich A; Smith CJ Nucl Med Biol; 2006 Jul; 33(5):625-34. PubMed ID: 16843837 [TBL] [Abstract][Full Text] [Related]
2. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3. Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Kannan R; Volkert WA; Hoffman TJ Cancer Res; 2003 Jul; 63(14):4082-8. PubMed ID: 12874010 [TBL] [Abstract][Full Text] [Related]
3. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior. Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099 [TBL] [Abstract][Full Text] [Related]
5. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677 [TBL] [Abstract][Full Text] [Related]
6. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies. Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195 [TBL] [Abstract][Full Text] [Related]
7. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. Smith CJ; Gali H; Sieckman GL; Hayes DL; Owen NK; Mazuru DG; Volkert WA; Hoffman TJ Nucl Med Biol; 2003 Feb; 30(2):101-9. PubMed ID: 12623108 [TBL] [Abstract][Full Text] [Related]
8. 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor. Lane SR; Veerendra B; Rold TL; Sieckman GL; Hoffman TJ; Jurisson SS; Smith CJ Nucl Med Biol; 2008 Apr; 35(3):263-72. PubMed ID: 18355681 [TBL] [Abstract][Full Text] [Related]
9. Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties. Smith CJ; Gali H; Sieckman GL; Higginbotham C; Volkert WA; Hoffman TJ Bioconjug Chem; 2003; 14(1):93-102. PubMed ID: 12526698 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of [99mTc-(CO)3-X-Y-Bombesin(7-14)NH2] conjugates for targeting gastrin-releasing peptide receptors overexpressed on breast carcinoma. Retzloff LB; Heinzke L; Figureoa SD; Sublett SV; Ma L; Sieckman GL; Rold TL; Santos I; Hoffman TJ; Smith CJ Anticancer Res; 2010 Jan; 30(1):19-30. PubMed ID: 20150613 [TBL] [Abstract][Full Text] [Related]
12. 18F-labeled BBN-RGD heterodimer for prostate cancer imaging. Li ZB; Wu Z; Chen K; Ryu EK; Chen X J Nucl Med; 2008 Mar; 49(3):453-61. PubMed ID: 18287274 [TBL] [Abstract][Full Text] [Related]
13. The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals. Prasanphanich AF; Lane SR; Figueroa SD; Ma L; Rold TL; Sieckman GL; Hoffman TJ; McCrate JM; Smith CJ In Vivo; 2007; 21(1):1-16. PubMed ID: 17354608 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro and in vivo evaluation of hypoxia-enhanced 111In-bombesin conjugates for prostate cancer imaging. Zhou Z; Wagh NK; Ogbomo SM; Shi W; Jia Y; Brusnahan SK; Garrison JC J Nucl Med; 2013 Sep; 54(9):1605-12. PubMed ID: 23896558 [TBL] [Abstract][Full Text] [Related]
15. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619 [TBL] [Abstract][Full Text] [Related]
16. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572 [TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours. Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924 [TBL] [Abstract][Full Text] [Related]
18. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P. Smilkov K; Janevik E; Guerrini R; Pasquali M; Boschi A; Uccelli L; Di Domenico G; Duatti A Appl Radiat Isot; 2014 Sep; 92():25-31. PubMed ID: 24973465 [TBL] [Abstract][Full Text] [Related]
19. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066 [TBL] [Abstract][Full Text] [Related]
20. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. Hoffman TJ; Gali H; Smith CJ; Sieckman GL; Hayes DL; Owen NK; Volkert WA J Nucl Med; 2003 May; 44(5):823-31. PubMed ID: 12732685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]